Cargando…

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)

BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. Treating individuals with MDR-TB infection to prevent progression to disease could be an effective public health strategy. Young children are at high risk of developing TB disease following infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seddon, James A., Garcia-Prats, Anthony J., Purchase, Susan E., Osman, Muhammad, Demers, Anne-Marie, Hoddinott, Graeme, Crook, Angela M., Owen-Powell, Ellen, Thomason, Margaret J., Turkova, Anna, Gibb, Diana M., Fairlie, Lee, Martinson, Neil, Schaaf, H. Simon, Hesseling, Anneke C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302301/ https://www.ncbi.nlm.nih.gov/pubmed/30572905 http://dx.doi.org/10.1186/s13063-018-3070-0

Ejemplares similares

Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children
por: Wademan, Dillon T., et al.
Publicado: (2022)

Toward a conceptual framework of the acceptability of tuberculosis treatment in children using a theory generative approach
por: Wademan, Dillon T., et al.
Publicado: (2022)

Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial
por: Chabala, Chishala, et al.
Publicado: (2018)

Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial
por: Wademan, D. T., et al.
Publicado: (2019)

A scoping review of patient-centred tuberculosis care interventions: Gaps and opportunities
por: Myburgh, Hanlie, et al.
Publicado: (2023)

Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study
por: Franck, Caroline, et al.
Publicado: (2014)

Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study
por: Seddon, James A, et al.
Publicado: (2013)

Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children
por: van der Laan, Louvina E, et al.
Publicado: (2023)

Opportunities for Mobile App–Based Adherence Support for Children With Tuberculosis in South Africa
por: Morse, Rachel M, et al.
Publicado: (2020)

Understanding the biology, morbidity and social contexts of adolescent tuberculosis: a prospective observational cohort study protocol (Teen TB)
por: Swanepoel, Jeremi, et al.
Publicado: (2022)

Shorter treatment for non-severe tuberculosis in African and Indian children
por: Turkova, Anna, et al.
Publicado: (2022)

Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register
por: Osman, Muhammad, et al.
Publicado: (2021)

The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study
por: Golla, Vera, et al.
Publicado: (2017)

Correction to: The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study
por: Golla, Vera, et al.
Publicado: (2017)

Tuberculosis: opportunities and challenges for the 90–90–90 targets in HIV-infected children
por: Rabie, Helena, et al.
Publicado: (2015)

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis
por: Seddon, James A., et al.
Publicado: (2016)

A systematic review of risk factors for mortality among tuberculosis patients in South Africa
por: Nicholson, Tamaryn J, et al.
Publicado: (2023)

Sugar and sugar-free liquid formulations of delamanid for patients with rifampicin-resistant TB
por: Taneja, R., et al.
Publicado: (2023)

Pediatric tuberculosis: clinical and epidemiological reflections from a highly endemic setting
por: Hesseling, Anneke
Publicado: (2010)

Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis
por: Rojanarat, Wipaporn, et al.
Publicado: (2012)

Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
por: Garcia-Prats, Anthony J., et al.
Publicado: (2019)

Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town
por: Bekker, Adrie, et al.
Publicado: (2016)

TB programme stakeholder views on lessons from the COVID-19 response in South Africa
por: Myburgh, H., et al.
Publicado: (2023)

Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis
por: Galileya, Lufina Tsirizani, et al.
Publicado: (2023)

A novel home-based method for preparing suspensions of anti-TB drugs
por: Taneja, R., et al.
Publicado: (2023)

Early interactions with newly diagnosed TB patients in hospital can support linkage to care
por: Viljoen, L., et al.
Publicado: (2022)

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial
por: Garcia-Prats, Anthony J., et al.
Publicado: (2022)

Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
por: Seddon, James A., et al.
Publicado: (2013)

Optimising computer aided detection to identify intra-thoracic tuberculosis on chest x-ray in South African children
por: Palmer, Megan, et al.
Publicado: (2023)

Human Cytomegalovirus Immunoglobulin G Response and Pulmonary Tuberculosis in Adolescents: A Case-Control Study
por: Swanepoel, Jeremi, et al.
Publicado: (2023)

Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel
por: Nachman, Sharon, et al.
Publicado: (2015)

Complementary surveillance strategies are needed to better characterise the epidemiology, care pathways and treatment outcomes of tuberculosis in children
por: du Preez, Karen, et al.
Publicado: (2018)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)

In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis
por: Akcali, Sinem, et al.
Publicado: (2005)

PLGA Carriers for Controlled Release of Levofloxacin in Anti-Tuberculosis Therapy
por: Antonov, Evgeny N., et al.
Publicado: (2022)

The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults
por: Moscibrodzki, Patricia, et al.
Publicado: (2021)

Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases
por: Schaaf, H Simon, et al.
Publicado: (2007)

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis
por: van der Laan, Louvina E., et al.
Publicado: (2021)

Drug concentration at the site of disease in children with pulmonary tuberculosis
por: Lopez-Varela, Elisa, et al.
Publicado: (2022)

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
por: Osman, Muhammad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_10og74cha4i8n11hd32tsg65ts